Italy· 043361017
DEFEROXAMINA NORIDEM
A deferoxamine product containing deferoxamina, registered in Italy by NORIDEM ENTERPRISES LTD, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Deferoxamine is registered in 16 of 19 countries.
Countries holding a registration under ATC V03AC01 (deferoxamine), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 10 of them publish a price we can compare per daily dose
Deferoxamine · ATC V03AC01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of deferoxamine costs, country by country.
Normalised to the WHO defined daily dose (2.8 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferoxamine · price per daily dose (2.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$48.38
- FR France$33.66
The record
At a glance
AIFA (Italy)- Active substance
- Deferoxamina
- Manufacturer
- NORIDEM ENTERPRISES LTD
- Country
- Italy (IT)
- ATC code
- V03AC01
- ATC class
- Deferoxamine
- Defined daily dose
- 2.8 g, P
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic043361017"500 MG POLVERE PER SOLUZIONE INIETTABILE O INFUSIONE" 10 FLACONCINI IN VETROEUR 43.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
49 interactions on record for deferoxamine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferoxamine · interactions on record
49 records
- 9 severe
- 5 moderate
- 35 info
Most severe, free to view
- CidofovirJ05AB12severe
- VigabatrinN03AG04severe
- InotersenN07XX15severe
- IopamidolV08AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deferoxamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsDesferal, poeder voor oplossing voor injectie of infusie 500 mgMitem Pharma
- NorwayDesferal2care4 ApS
- SwedenDesferal 500 mg Pulver till injektions-/infusionsvätska, lösningMITEM PHARMA
- SpainDESFERIN 500 mg POLVO PARA SOLUCION INYECTABLE O PERFUSIONMitem Pharma
- IrelandDesferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for InfusionMitem Pharma
- IcelandDesferalMitem Pharma
- United KingdomDesferal 2g powder for solution for injection vialsNovartis Pharmaceuticals UK Ltd
- United StatesDeferoxamineFresenius Kabi USA, LLC
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Desferal
- Belgium · Desferal
- Bulgaria · Десферал
- Cyprus · Deferoxamine Noridem
- Czechia · Desferal
- Germany · Deferoxaminmesilat Noridem Enterprises, Desferal
- Denmark · Desferal
- Spain · Desferin
- Finland · Desferal
- France · Desferal
- United Kingdom (Northern Ireland) · Desferrioxamine Mesilate Noridem Enterprises
- Greece · Deferoxamine Noridem, Demoferidon
- Hungary · Desferal
- Ireland · Desferal
- Iceland · Desferal
- Luxembourg · Desferal
- Netherlands · Desferal
- Norway · Desferal
- Poland · Desferal
- Portugal · Desferal
- Romania · Desferal
- Sweden · Desferal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/34ac8841-50ad-412d-9065-2bc68ae72c1f GET /v1/drugs/34ac8841-50ad-412d-9065-2bc68ae72c1f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"500 MG POLVERE PER SOLUZIONE INIETTABILE O INFUSIONE\" 10 FLACONCINI IN VETRO",
"source": "aifa",
"currency": "EUR",
"substance": "Deferoxamina",
"reference_pack": "10 UNITA' 500 MG - USO PARENTERALE",
"public_price_eur": 43.53,
"ssn_reference_price_eur": 43.53
}See everything about deferoxamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.